You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

108 search results for: type 2 inflammation

Skin Barrier Dysfunction and <b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis

videoanimation

Skin Barrier Dysfunction and Type 2 Inflammation in Atopic Dermatitis

2 min

Dermatology

Learn more about how the exaggerated immune response due to chronic and systemic type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis

expert video

Type 2 Inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis

10 min

Dermatology

In this ADVENT symposium at the 2024 Diversity in Dermatology conference, Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation.

<b>Type</b> <b>2</b> <b>Inflammation</b> and Infections

slide presentation

Type 2 Inflammation and Infections

15 min

Type 2 Inflammation

This slide deck will provide an overview of the concepts of type 1, type 2, and type 3 immune responses.

expert video

Under the Skin: Autoimmunity and Type 2 Inflammation in Bullous Pemphigoid (BP)

10 min

Dermatology

Join Drs. Victoria Werth and Teri Greiling as they explain the autoimmunity driving bullous pemphigoid (BP), as well as the important role type 2 inflammation plays in BP.

<b>Type</b> <b>2</b> <b>Inflammation</b> Is a Significant Driver of Pediatric Severe Asthma

Infographic

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

5 min

Pulmonology

Learn about the role of type 2 inflammation in the burden and pathophysiology of severe asthma in pediatric patients

Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Prurigo Nodularis Part <b>2</b>: Itch and Skin Lesions

expert video

Role of Type 2 Inflammation in Prurigo Nodularis Part 2: Itch and Skin Lesions

13 min

Dermatology

Dive deeper into the specific role of type 2 inflammation in neuroimmune dysregulation and dermal fibrosis that leads to itch and skin lesions seen in patients with prurigo nodularis with Dr. Raj Chovatiya in the second part of this discussion.

ADVENT On Air | Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in COPD

Podcast

ADVENT On Air | Role of Type 2 Inflammation in COPD

21 min

Pulmonology

Drs Stephanie Christenson and Jean Bourbeau explore the role of type 2 inflammation in Chronic Obstructive Pulmonary Disease (COPD).

FeNO: A Biomarker of <b>Type</b> <b>2</b> <b>Inflammation</b> in Pediatric Asthma Patients

Infographic

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients

5 min

Pulmonology

Learn about the role of FeNO as a noninvasive test to identify type 2 inflammation in pediatric patients with asthma.

ERS <b>2</b>0<b>2</b>4 | Unraveling the Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in COPD

expert video

ERS 2024 | Unraveling the Role of Type 2 Inflammation in COPD

8 min

Pulmonology

Professor Mona Bafadhel presents a comprehensive overview of type 2 inflammation in COPD, exploring its underlying mechanisms, clinical manifestations, and implications for patient outcomes.

Infographic

The Role of Type 2 Inflammation in Multiple Disease Trajectories

5 min

Dermatology

How type 2 inflammation drives atopic dermatitis and underlies other atopic diseases across multiple disease trajectories including the atopic march.

expert video

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

45 min

Pulmonology

Professors Henrik Watz, Mona Bafadhel, and Alberto Papi discuss the pathophysiology of COPD with type 2 inflammation and review current and emerging biologic therapies

<b>Type</b> <b>2</b> <b>Inflammation</b> in CRSwNP: Interactive Patient Case

interactivity

Type 2 Inflammation in CRSwNP: Interactive Patient Case

10 min

Rhinology

An interactive patient case tool involving a deep dive into the patient perspective of living with CRSwNP.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region